Sidley Updates
Top 10 FDA Areas We Are Watching For 2026
January 12, 2026
As 2026 begins, there is much to look forward to as companies and investors in the life sciences and medtech industries navigate a profoundly changing regulatory environment at FDA. With 2025 witnessing generational changes at FDA, we’re keeping an eye on opportunities and challenges for the year to come.
Attorney Advertising—Sidley Austin LLP is a global law firm. Our addresses and contact information can be found at www.sidley.com/en/locations/offices.
Sidley provides this information as a service to clients and other friends for educational purposes only. It should not be construed or relied on as legal advice or to create a lawyer-client relationship. Readers should not act upon this information without seeking advice from professional advisers. Sidley and Sidley Austin refer to Sidley Austin LLP and affiliated partnerships as explained at www.sidley.com/disclaimer.
© Sidley Austin LLP
Contacts
Capabilities
Suggested News & Insights
Korea Night @ JPM 2026Wednesday, January 14, 2026Global IR Pitching @ JPM 2026 (Co-hosted by KoreaBIO and Sidley)Tuesday, January 13, 2026Recharge & Recaffeinate with Sidley @ JPMMonday, January 12, 2026 – Tuesday, January 13, 2026Biotech Dealmaking – Regulatory Considerations for the Next Wave of Development-Stage Transactions – Program and Lunch @ JPM 2026Monday, January 12, 2026Connecting Clusters of Excellence: Europe as Your Gateway to Global Success – Organized by Biovia, Health Campus Limburg DC, SidleyMonday, January 12, 2026Impact of U.S. FDA Warning Letters in Europe: Practical Considerations for IndustryJanuary 12, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory